WEE1 and cancer: While the concept of reactivating tumor suppressor proteins has been appreciated as a potential anti-cancer therapeutic strategy for decades, progress in developing therapies that target tumor suppressor proteins has lagged behind the successful development of therapies targeting oncoproteins such as protein kinases.